Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T73482 | Target Info | |||
Target Name | Orexin receptor type 1 (HCRTR1) | ||||
Synonyms | Ox1r; Ox1-R; Ox-1-R; Orexin-1 receptor; Hypocretin receptor type 1; HFGAN72 receptor; 7-transmembrane G-protein coupledneuropeptide receptor | ||||
Target Type | Clinical trial Target | ||||
Gene Name | HCRTR1 | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 2-Hydroxymethyl-6-octylsulfanyl-tetrahydro-pyran-3,4,5-triol | Ligand Info | |||
Canonical SMILES | CCCCCCCCSC1C(C(C(C(O1)CO)O)O)O | ||||
InChI | 1S/C14H28O5S/c1-2-3-4-5-6-7-8-20-14-13(18)12(17)11(16)10(9-15)19-14/h10-18H,2-9H2,1H3/t10-,11-,12+,13-,14+/m1/s1 | ||||
InChIKey | CGVLVOOFCGWBCS-RGDJUOJXSA-N | ||||
PubChem Compound ID | 656909 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6TQ4 Crystal structure of the Orexin-1 receptor in complex with Compound 16 | ||||||
Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | Yes | [1] |
PDB Sequence |
ASEDEFLRYL
35 WRDYLYPKQY45 AWVLIAAYVA55 VFVVALVGNT65 LVCLAVWRNH75 HMRTVTNYFL 85 VNLSLADVLA95 TAICLPASLL105 VDITESWLFG115 HALCKVIPYL125 QAVSVSVAVL 135 TLSFIALDRW145 YAICHPLLFK155 STARRALGSI165 LGIWAVSLAI175 MVPQAAVMEC 185 SSVFSVCDER205 WADDLAPKIY215 HSCFFIVTYL225 APLGLMAMAY235 FQIFRKLWVK 288 QMRARRKTAK298 MLMVVVLVFA308 LCYLPISVLN318 VLKRVFGMFR328 QASDREAVYA 338 AFTFSHWLVY348 ANSAANPIIY358 NFLSGKFREQ368 FKAAFSW
|
|||||
|
ARG37
3.174
ASP38
3.222
TYR41
3.874
PRO42
3.715
TYR45
3.524
ALA46
3.587
LEU49
4.880
SER103
3.857
VAL106
3.731
ASP107
4.751
ILE108
3.928
GLU110
2.827
SER111
3.836
TRP112
3.707
GLN126
3.880
LEU135
4.583
PHE139
3.428
LEU152
4.329
LEU153
3.913
LYS155
4.545
ARG160
3.757
GLY163
3.325
SER164
3.394
GLY167
4.487
ALA181
4.994
VAL182
4.501
SER200
4.989
VAL201
3.914
CYS202
2.970
ASP203
3.543
ARG205
3.885
TRP206
4.160
ALA207
3.918
ASP208
3.197
LEU210
3.862
ALA211
3.380
LYS213
3.537
ILE214
4.025
SER217
3.565
LYS321
3.160
VAL323
3.330
PHE324
3.047
PHE327
3.590
GLU334
3.772
VAL336
4.124
TYR337
4.332
PHE340
4.011
HIS344
3.334
VAL347
3.622
TYR348
3.313
|
|||||
PDB ID: 6TP6 Crystal structure of the Orexin-1 receptor in complex with filorexant | ||||||
Method | X-ray diffraction | Resolution | 2.34 Å | Mutation | Yes | [1] |
PDB Sequence |
AASEDEFLRY
34 LWRDYLYPKQ44 YAWVLIAAYV54 AVFVVALVGN64 TLVCLAVWRN74 HHMRTVTNYF 84 LVNLSLADVL94 ATAICLPASL104 LVDITESWLF114 GHALCKVIPY124 LQAVSVSVAV 134 LTLSFIALDR144 WYAICHPLLF154 KSTARRALGS164 ILGIWAVSLA174 IMVPQAAVME 184 CSSVLAFSVC202 DERWADDLAP212 KIYHSCFFIV222 TYLAPLGLMA232 MAYFQIFRKL 242 WTSAEVKQMR291 ARRKTAKMLM301 VVVLVFALCY311 LPISVLNVLK321 RVFGMFRQAS 331 DREAVYAAFT341 FSHWLVYANS351 AANPIIYNFL361 SGKFREQFKA371 AFSWW |
|||||
|
TRP36
3.493
ARG37
2.624
ASP38
3.466
TYR39
4.697
TYR41
3.599
PRO42
3.527
TYR45
3.710
ALA46
3.679
VAL48
4.112
LEU49
3.555
ALA52
3.795
TYR53
4.642
ASP107
4.528
ILE108
3.996
VAL182
4.216
ARG205
2.633
|
|||||
PDB ID: 6TQ6 Crystal structure of the Orexin-1 receptor in complex with Compound 14 | ||||||
Method | X-ray diffraction | Resolution | 2.55 Å | Mutation | Yes | [1] |
PDB Sequence |
EDEFLRYLWR
37 DYLYPKQYAW47 VLIAAYVAVF57 VVALVGNTLV67 CLAVWRNHHM77 RTVTNYFLVN 87 LSLADVLATA97 ICLPASLLVD107 ITESWLFGHA117 LCKVIPYLQA127 VSVSVAVLTL 137 SFIALDRWYA147 ICHPLLFKST157 ARRALGSILG167 IWAVSLAIMV177 PQAAVMECSS 187 FSVCDERWAD208 DLAPKIYHSC218 FFIVTYLAPL228 GLMAMAYFQI238 FRKLWGQMRA 292 RRKTAKMLMV302 VVLVFALCYL312 PISVLNVLKR322 VFGMFRQASD332 REAVYAAFTF 342 SHWLVYANSA352 ANPIIYNFLS362 GKFREQFKAA372 FSW
|
|||||
|
LEU113
3.348
PHE114
3.697
GLY115
3.815
LEU118
3.771
LEU135
4.139
PHE139
3.644
ARG160
3.765
GLY163
3.221
SER164
3.051
GLY167
4.228
VAL171
4.809
|
|||||
PDB ID: 6TQ7 Crystal structure of the Orexin-1 receptor in complex with SB-334867 | ||||||
Method | X-ray diffraction | Resolution | 2.66 Å | Mutation | Yes | [1] |
PDB Sequence |
YAWVLIAAYV
54 AVFVVALVGN64 TLVCLAVWRN74 HHMRTVTNYF84 LVNLSLADVL94 ATAICLPASL 104 LVDITESWLF114 GHALCKVIPY124 LQAVSVSVAV134 LTLSFIALDR144 WYAICHPLLF 154 KSTARRALGS164 ILGIWAVSLA174 IMVPQAAVME184 CSSVLPELAA194 RTRAFSVCDE 204 RWADDLAPKI214 YHSCFFIVTY224 LAPLGLMAMA234 YFQIFRKLWG244 RQIPGTTSAE 286 VKQMRARRKT296 AKMLMVVVLV306 FALCYLPISV316 LNVLKRVFGM326 FRQASDREAV 336 YAAFTFSHWL346 VYANSAANPI356 IYNFLSGKFR366 EQFKAAFSWW376 L |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:120 or .A:181 or .A:182 or .A:184 or .A:192 or .A:195 or .A:196 or .A:197 or .A:199 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:213 or .A:214 or .A:217 or .A:218 or .A:228 or .A:232 or .A:235 or .A:236 or .A:239 or .A:243 or .A:298 or .A:301 or .A:304 or .A:305 or .A:308 or .A:323 or .A:324; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
LYS120
4.764
ALA181
3.227
VAL182
4.660
GLU184
2.422
LEU192
4.701
ARG195
3.536
THR196
2.765
ARG197
3.748
PHE199
3.615
ARG205
2.631
TRP206
3.700
ALA207
3.175
ASP208
2.763
ASP209
3.399
LEU210
3.935
ALA211
3.913
LYS213
3.215
|
|||||
PDB ID: 6TP3 Crystal structure of the Orexin-1 receptor in complex with daridorexant | ||||||
Method | X-ray diffraction | Resolution | 3.04 Å | Mutation | Yes | [1] |
PDB Sequence |
LRYLWRDYLY
41 PKQYAWVLIA51 AYVAVFVVAL61 VGNTLVCLAV71 WRNHHMRTVT81 NYFLVNLSLA 91 DVLATAICLP101 ASLLVDITES111 WLFGHALCKV121 IPYLQAVSVS131 VAVLTLSFIA 141 LDRWYAICHP151 LLFKSTARRA161 LGSILGIWAV171 SLAIMVPQAA181 VMECSSVLPE 191 LAARTRAFSV201 CDERWADDLA211 PKIYHSCFFI221 VTYLAPLGLM231 AMAYFQIFRK 241 LWGRQIPGTT251 SAEVKQMRAR293 RKTAKMLMVV303 VLVFALCYLP313 ISVLNVLKRV 323 FGMFRQASDR333 EAVYAAFTFS343 HWLVYANSAA353 NPIIYNFLSG363 KFREQFKAAF 373 SWWL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:37 or .A:38 or .A:42 or .A:97 or .A:98 or .A:101 or .A:102 or .A:114 or .A:115 or .A:116 or .A:117 or .A:118 or .A:122 or .A:152 or .A:153 or .A:182 or .A:192 or .A:195 or .A:196 or .A:197 or .A:199 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:213 or .A:323 or .A:324; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG37
3.075
ASP38
3.321
PRO42
4.509
ALA97
4.581
ILE98
3.302
PRO101
3.437
ALA102
3.491
PHE114
3.303
GLY115
4.294
HIS116
4.789
ALA117
3.927
LEU118
3.656
ILE122
3.755
LEU152
4.359
LEU153
3.622
VAL182
4.780
|
|||||
PDB ID: 6TOD Crystal structure of the Orexin-1 receptor in complex with EMPA | ||||||
Method | X-ray diffraction | Resolution | 2.11 Å | Mutation | Yes | [1] |
PDB Sequence |
YAWVLIAAYV
54 AVFVVALVGN64 TLVCLAVWRN74 HHMRTVTNYF84 LVNLSLADVL94 ATAICLPASL 104 LVDITESWLF114 GHALCKVIPY124 LQTVSVSVAV134 LTLSFIALDR144 WYAICHPLLF 154 KSTARRALGS164 ILGIWAVSLA174 IMVPQAAVME184 CSSVLPELAA194 RTRAFSVCDE 204 RWADDLAPKI214 YHSCFFIVTY224 LAPLGLMAMA234 YFQIFRKLWG244 RQIPGTTSEV 287 KQMRARRKTA297 KMLMVVVLVF307 ALCYLPISVL317 NVLKRVFGMF327 RQASDREAVY 337 AAFTFSHWLV347 YANSAANPII357 YNFLSGKFRE367 QFKAAFSWWL377 P |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:53 or .A:54 or .A:57 or .A:58 or .A:71 or .A:72 or .A:78 or .A:83 or .A:86 or .A:87 or .A:90 or .A:93 or .A:94 or .A:97 or .A:98 or .A:100 or .A:101 or .A:102 or .A:104 or .A:105 or .A:113 or .A:114 or .A:115 or .A:116 or .A:117 or .A:118 or .A:120 or .A:121 or .A:122 or .A:124 or .A:135 or .A:139 or .A:145 or .A:149 or .A:150 or .A:153 or .A:160 or .A:162 or .A:163 or .A:164 or .A:165 or .A:166 or .A:167 or .A:168 or .A:169 or .A:171 or .A:173 or .A:177 or .A:180 or .A:181 or .A:182 or .A:184 or .A:197 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:213 or .A:214 or .A:217 or .A:220 or .A:221 or .A:232 or .A:233 or .A:236 or .A:237 or .A:239 or .A:243 or .A:298 or .A:301 or .A:302 or .A:305 or .A:312 or .A:316 or .A:317 or .A:319 or .A:320 or .A:323 or .A:324 or .A:326 or .A:327 or .A:332 or .A:335 or .A:336 or .A:339; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TYR53
4.082
VAL54
2.967
PHE57
3.350
VAL58
4.550
VAL71
4.118
TRP72
3.855
ARG78
3.833
TYR83
3.640
VAL86
3.951
ASN87
4.650
LEU90
3.409
VAL93
3.823
LEU94
3.929
ALA97
3.680
ILE98
3.354
LEU100
3.831
PRO101
3.337
ALA102
4.141
LEU104
3.872
LEU105
3.703
LEU113
3.638
PHE114
3.675
GLY115
3.786
HIS116
3.442
ALA117
3.408
LEU118
3.760
LYS120
3.364
VAL121
4.235
ILE122
4.134
TYR124
3.658
LEU135
4.724
PHE139
3.554
TRP145
3.634
CYS149
4.542
HIS150
2.766
LEU153
3.836
ARG160
3.257
LEU162
3.777
GLY163
3.519
SER164
3.216
ILE165
4.058
LEU166
3.484
GLY167
3.638
ILE168
3.970
TRP169
3.568
VAL171
3.654
LEU173
3.745
VAL177
3.036
ALA180
3.373
ALA181
3.198
VAL182
3.838
GLU184
3.287
ARG197
2.769
ARG205
3.282
TRP206
3.070
ALA207
3.169
ASP208
3.308
ASP209
2.952
LEU210
3.616
ALA211
3.586
LYS213
2.839
ILE214
4.111
SER217
3.353
PHE220
3.681
ILE221
3.726
ALA232
3.900
MET233
4.320
PHE236
3.876
GLN237
2.687
PHE239
3.770
TRP243
3.912
LYS298
4.162
MET301
3.924
VAL302
3.865
LEU305
4.210
LEU312
3.976
VAL316
3.696
LEU317
4.354
VAL319
3.676
LEU320
3.752
VAL323
3.821
PHE324
3.079
MET326
3.637
PHE327
3.707
ASP332
3.524
ALA335
3.913
VAL336
3.711
ALA339
3.906
|
|||||
PDB ID: 6TOS Crystal structure of the Orexin-1 receptor in complex with GSK1059865 | ||||||
Method | X-ray diffraction | Resolution | 2.13 Å | Mutation | Yes | [1] |
PDB Sequence |
SEDEFLRYLW
36 RDYLYPKQYA46 WVLIAAYVAV56 FVVALVGNTL66 VCLAVWRNHH76 MRTVTNYFLV 86 NLSLADVLAT96 AICLPASLLV106 DITESWLFGH116 ALCKVIPYLQ126 AVSVSVAVLT 136 LSFIALDRWY146 AICHPLLFKS156 TARRALGSIL166 GIWAVSLAIM176 VPQAAVMECS 186 SVRAFSVCDE204 RWADDLAPKI214 YHSCFFIVTY224 LAPLGLMAMA234 YFQIFRKLWG 244 EVKQMRARRK295 TAKMLMVVVL305 VFALCYLPIS315 VLNVLKRVFG325 MFRQASDREA 335 VYAAFTFSHW345 LVYANSAANP355 IIYNFLSGKF365 REQFKAAFSW375 WL |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:36 or .A:37 or .A:41 or .A:44 or .A:45 or .A:48 or .A:49 or .A:52 or .A:53 or .A:113 or .A:114 or .A:115 or .A:118 or .A:120 or .A:121 or .A:124 or .A:145 or .A:150 or .A:173 or .A:177 or .A:180 or .A:181 or .A:182 or .A:184 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:213 or .A:214 or .A:217 or .A:236 or .A:237 or .A:240 or .A:317 or .A:323 or .A:324 or .A:327 or .A:330 or .A:331 or .A:332 or .A:333 or .A:334 or .A:335 or .A:336 or .A:338 or .A:339 or .A:341 or .A:342 or .A:345; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
TRP36
2.749
ARG37
3.726
TYR41
3.387
GLN44
3.486
TYR45
3.627
VAL48
3.816
LEU49
3.789
ALA52
3.664
TYR53
4.638
LEU113
2.711
PHE114
3.411
GLY115
3.498
LEU118
3.758
LYS120
3.653
VAL121
4.471
TYR124
3.626
TRP145
3.235
HIS150
3.105
LEU173
3.788
VAL177
3.715
ALA180
3.981
ALA181
3.599
VAL182
4.554
GLU184
4.932
ARG205
2.626
TRP206
3.522
ALA207
2.734
ASP208
4.603
ASP209
3.425
LEU210
3.926
ALA211
4.614
LYS213
2.784
ILE214
4.161
SER217
3.292
PHE236
4.101
GLN237
2.724
ARG240
3.532
LEU317
4.054
VAL323
2.752
PHE324
3.639
PHE327
4.047
ALA330
3.679
SER331
3.325
ASP332
3.256
ARG333
3.438
GLU334
3.644
ALA335
3.751
VAL336
4.298
ALA338
3.721
ALA339
3.903
THR341
3.861
PHE342
3.977
TRP345
3.833
|
|||||
PDB ID: 6TOT Crystal structure of the Orexin-1 receptor in complex with lemborexant | ||||||
Method | X-ray diffraction | Resolution | 2.22 Å | Mutation | Yes | [1] |
PDB Sequence |
SEDEFLRYLW
36 RDYLYPKQYA46 WVLIAAYVAV56 FVVALVGNTL66 VCLAVWRNHH76 MRTVTNYFLV 86 NLSLADVLAT96 AICLPASLLV106 DITESWLFGH116 ALCKVIPYLQ126 AVSVSVAVLT 136 LSFIALDRWY146 AICHPLLFKS156 TARRALGSIL166 GIWAVSLAIM176 VPQAAVMECS 186 SVRAFSVCDE204 RWADDLAPKI214 YHSCFFIVTY224 LAPLGLMAMA234 YFQIFRKLWE 286 VKQMRARRKT296 AKMLMVVVLV306 FALCYLPISV316 LNVLKRVFGM326 FRQASDREAV 336 YAAFTFSHWL346 VYANSAANPI356 IYNFLSGKFR366 EQFKAAFSWW376 |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:37 or .A:38 or .A:39 or .A:41 or .A:42 or .A:45 or .A:46 or .A:49 or .A:107 or .A:108 or .A:181 or .A:182 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:213 or .A:214 or .A:217 or .A:323 or .A:324 or .A:325 or .A:334; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG37
2.653
ASP38
3.371
TYR39
4.704
TYR41
3.739
PRO42
3.540
TYR45
3.696
ALA46
3.744
LEU49
3.974
ASP107
4.847
ILE108
3.952
ALA181
4.780
VAL182
4.355
ARG205
2.686
|
|||||
PDB ID: 6TO7 Crystal structure of the Orexin-1 receptor in complex with suvorexant at 2.29 A resolution | ||||||
Method | X-ray diffraction | Resolution | 2.26 Å | Mutation | Yes | [1] |
PDB Sequence |
YAWVLIAAYV
54 AVFVVALVGN64 TLVCLAVWRN74 HHMRTVTNYF84 LVNLSLADVL94 ATAICLPASL 104 LVDITESWLF114 GHALCKVIPY124 LQAVSVSVAV134 LTLSFIALDR144 WYAICHPLLF 154 KSTARRALGS164 ILGIWAVSLA174 IMVPQAAVME184 CSSVLPELAA194 RTRAFSVCDE 204 RWADDLAPKI214 YHSCFFIVTY224 LAPLGLMAMA234 YFQIFRKLWG244 RIPGTTSAEV 287 KQMRARRKTA297 KMLMVVVLVF307 ALCYLPISVL317 NVLKRVFGMF327 RQASDREAVY 337 AAFTFSHWLV347 YANSAANPII357 YNFLSGKFRE367 QFKAAFSWWL377 |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:54 or .A:55 or .A:56 or .A:57 or .A:59 or .A:97 or .A:100 or .A:101 or .A:104 or .A:113 or .A:114 or .A:115 or .A:117 or .A:118 or .A:120 or .A:121 or .A:124 or .A:125 or .A:149 or .A:150 or .A:151 or .A:152 or .A:153 or .A:173 or .A:177 or .A:180 or .A:181 or .A:182 or .A:183 or .A:184 or .A:197 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:212 or .A:213 or .A:214 or .A:217 or .A:218 or .A:220 or .A:221 or .A:224 or .A:225 or .A:228 or .A:229 or .A:232 or .A:233 or .A:235 or .A:236 or .A:237 or .A:239 or .A:240 or .A:241 or .A:301 or .A:302 or .A:304 or .A:305 or .A:306 or .A:308 or .A:309 or .A:310 or .A:312 or .A:313 or .A:315 or .A:316 or .A:317 or .A:319 or .A:320 or .A:323 or .A:324 or .A:326 or .A:327 or .A:332 or .A:335 or .A:336 or .A:339 or .A:342 or .A:343 or .A:345 or .A:346 or .A:349 or .A:352 or .A:353 or .A:356 or .A:357 or .A:360 or .A:361; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
VAL54
4.242
ALA55
4.126
VAL56
4.084
PHE57
3.514
VAL59
3.888
ALA97
4.072
LEU100
4.446
PRO101
3.817
LEU104
4.270
LEU113
4.400
PHE114
3.839
GLY115
4.685
ALA117
4.327
LEU118
3.695
LYS120
3.736
VAL121
3.922
TYR124
3.426
LEU125
4.950
CYS149
3.255
HIS150
3.261
PRO151
3.505
LEU152
3.506
LEU153
4.114
LEU173
3.704
VAL177
3.798
ALA180
3.489
ALA181
3.327
VAL182
3.407
MET183
3.391
GLU184
3.726
ARG197
2.802
ARG205
2.717
TRP206
3.324
ALA207
3.393
ASP208
3.654
ASP209
3.333
LEU210
4.522
ALA211
3.726
PRO212
4.205
LYS213
2.858
ILE214
3.986
SER217
3.644
CYS218
4.292
PHE220
3.743
ILE221
3.944
TYR224
3.871
LEU225
4.137
LEU228
3.745
GLY229
3.658
ALA232
3.747
MET233
4.030
TYR235
3.776
PHE236
3.875
GLN237
3.070
PHE239
3.658
ARG240
3.461
LYS241
3.582
MET301
3.449
VAL302
4.179
VAL304
3.849
LEU305
4.401
VAL306
4.459
ALA308
3.745
LEU309
3.700
CYS310
3.943
LEU312
3.773
PRO313
3.971
SER315
4.875
VAL316
3.907
LEU317
3.786
VAL319
3.752
LEU320
3.840
VAL323
3.610
PHE324
3.158
MET326
3.374
PHE327
3.113
ASP332
3.484
ALA335
3.666
VAL336
3.914
ALA339
3.824
PHE342
3.920
SER343
3.979
TRP345
4.884
LEU346
3.802
ALA349
3.427
ALA352
3.917
ALA353
4.152
ILE356
3.994
ILE357
3.717
PHE360
4.594
LEU361
4.258
|
|||||
PDB ID: 6TQ9 Crystal structure of the Orexin-1 receptor in complex with SB-408124 | ||||||
Method | X-ray diffraction | Resolution | 2.65 Å | Mutation | Yes | [1] |
PDB Sequence |
SEDEFLRYLW
36 RDYLYPKQYA46 WVLIAAYVAV56 FVVALVGNTL66 VCLAVWRNHH76 MRTVTNYFLV 86 NLSLADVLAT96 AICLPASLLV106 DITESWLFGH116 ALCKVIPYLQ126 AVSVSVAVLT 136 LSFIALDRWY146 AICHPLLFKS156 TARRALGSIL166 GIWAVSLAIM176 VPQAAVMECS 186 SVAFSVCDER205 WADDLAPKIY215 HSCFFIVTYL225 APLGLMAMAY235 FQIFRKLWGT 250 TSAEVKQMRA292 RRKTAKMLMV302 VVLVFALCYL312 PISVLNVLKR322 VFGMFRQASD 332 REAVYAAFTF342 SHWLVYANSA352 ANPIIYNFLS362 GKFREQFKAA372 FSWW |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:37 or .A:38 or .A:41 or .A:42 or .A:45 or .A:46 or .A:49 or .A:108 or .A:139 or .A:159 or .A:160 or .A:163 or .A:164 or .A:167 or .A:170 or .A:181 or .A:182 or .A:205 or .A:206 or .A:207 or .A:208 or .A:209 or .A:210 or .A:211 or .A:213 or .A:214 or .A:217 or .A:218 or .A:323 or .A:324 or .A:326 or .A:334; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG37
2.623
ASP38
3.158
TYR41
3.329
PRO42
3.384
TYR45
3.285
ALA46
3.120
LEU49
4.374
ILE108
4.286
PHE139
2.994
ARG159
4.626
ARG160
3.218
GLY163
3.670
SER164
3.079
GLY167
4.650
ALA170
4.391
ALA181
3.753
|
|||||
PDB ID: 6TP4 Crystal structure of the Orexin-1 receptor in complex with ACT-462206 | ||||||
Method | X-ray diffraction | Resolution | 3.01 Å | Mutation | Yes | [1] |
PDB Sequence |
EDEFLRYLWR
37 DYLYPKQYAW47 VLIAAYVAVF57 VVALVGNTLV67 CLAVWRNHHM77 RTVTNYFLVN 87 LSLADVLATA97 ICLPASLLVD107 ITESWLFGHA117 LCKVIPYLQA127 VSVSVAVLTL 137 SFIALDRWYA147 ICHPLLFKST157 ARRALGSILG167 IWAVSLAIMV177 PQAAVMECSS 187 VFSVCDERWA207 DDLAPKIYHS217 CFFIVTYLAP227 LGLMAMAYFQ237 IFRKLWSAEV 287 KQMRARRKTA297 KMLMVVVLVF307 ALCYLPISVL317 NVLKRVFGMF327 RQASDREAVY 337 AAFTFSHWLV347 YANSAANPII357 YNFLSGKFRE367 QFKAAFSW
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .SOG or .SOG2 or .SOG3 or :3SOG;style chemicals stick;color identity;select .A:37 or .A:38 or .A:39 or .A:41 or .A:42 or .A:45 or .A:155 or .A:157 or .A:159 or .A:160 or .A:162 or .A:163 or .A:166 or .A:181 or .A:182 or .A:205 or .A:206 or .A:207 or .A:208 or .A:211 or .A:334 or .A:335 or .A:338; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ARG37
3.132
ASP38
3.305
TYR39
4.950
TYR41
2.992
PRO42
3.496
TYR45
3.792
LYS155
3.050
THR157
3.427
ARG159
3.011
ARG160
3.137
LEU162
4.360
GLY163
4.010
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J Med Chem. 2020 Feb 27;63(4):1528-1543. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.